{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:59:30Z","timestamp":1790135970424,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH118151"],"award-info":[{"award-number":["R01MH118151"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","academicpedsjnl.net","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Pediatrics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.acap.2024.04.005","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T12:23:08Z","timestamp":1713183788000},"page":"1110-1115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis\u00a0Among Young Adult Sexual Minority Men and Transgender Women"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8187-9234","authenticated-orcid":false,"given":"Terrance","family":"Weeden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Schnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8907-7706","authenticated-orcid":false,"given":"Marbella","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7077-535X","authenticated-orcid":false,"given":"Thomas","family":"Scherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Kuhns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acap.2024.04.005_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/aid.2012.0089","article-title":"Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure","volume":"29","author":"Castillo-Mancilla","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.acap.2024.04.005_bib2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.acap.2024.04.005_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/lgbt.2020.0232","article-title":"The pre-exposure prophylaxis cascade in at-risk transgender men who have sex with men in the United States","volume":"8","author":"Reisner","year":"2021","journal-title":"LGBT Health"},{"key":"10.1016\/j.acap.2024.04.005_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25461","article-title":"National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017","volume":"23","author":"Sullivan","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.acap.2024.04.005_bib5","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10508-017-1049-7","article-title":"Preferences for injectable PrEP among young US\u00a0cisgender men and transgender women and men who have sex with men","volume":"47","author":"Biello","year":"2018","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.acap.2024.04.005_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100650","article-title":"Understanding pre-exposure prophylaxis (PrEP) regimen use: switching and discontinuing daily and event-driven PrEP among men who have sex with men","volume":"29-30","author":"Coyer","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.acap.2024.04.005_bib7","article-title":"Demographic characteristics associated with the use of HIV pre-exposure prophylaxis (PrEP) in an urban, community health center","volume":"15","author":"Caponi","year":"2019","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.acap.2024.04.005_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22692","article-title":"Characterization of HIV preexposure prophylaxis use behaviors and HIV incidence among US adults in an integrated health care system","volume":"4","author":"Hojilla","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.acap.2024.04.005_bib9","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2105\/AJPH.2018.304623","article-title":"HIV preexposure prophylaxis initiation at a large community clinic: differences between eligibility, awareness, and uptake","volume":"108","author":"Shover","year":"2018","journal-title":"Am J Public Health"},{"key":"10.1016\/j.acap.2024.04.005_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.annepidem.2017.02.003","article-title":"Lifetime risk of a diagnosis of HIV infection in the United States","volume":"27","author":"Hess","year":"2017","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.acap.2024.04.005_bib11","unstructured":"American Civil Liberties Union. Mapping attacks on LGBTQ rights in US\u00a0State Legislatures. Available from: \u3008https:\/\/www.aclu.org\/legislative-attacks-on-lgbtq-rights\u3009.\u00a0Accessed July 8,\u00a02023."},{"key":"10.1016\/j.acap.2024.04.005_bib12","unstructured":"McNamara M, Harsono\u00a0D, Edelman\u00a0E, et al. Braidwood misreads the science: the PrEP promotes public health for the entire community.\u00a0Available from: \u3008https:\/\/law.yale.edu\/sites\/default\/files\/documents\/pdf\/prep_report_final_feb_13_2023_rev.pdf\u3009.\u00a0Accessed May 21,\u00a02023."},{"key":"10.1016\/j.acap.2024.04.005_bib13","unstructured":"US\u00a0Department of Health and Human Services (HHS). EHE overview. In: HHS, editor. \u3008https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/overview\u3009: HHS; 2023."},{"key":"10.1016\/j.acap.2024.04.005_bib14","unstructured":"Centers for Disease Control and Prevention (CDC). PrEP for HIV prevention in the US: fact sheet 2021. Available from: \u3008https:\/\/www.cdc.gov\/nchhstp\/newsroom\/fact-sheets\/hiv\/PrEP-for-hiv-prevention-in-the-US-factsheet.html\u3009."},{"key":"10.1016\/j.acap.2024.04.005_bib15","unstructured":"Centers for Disease Control and Prevention (CDC). Diagnoses of HIV infection in the United States and dependent areas, 2021. HIV Surveillance Report, 2023; 34."},{"key":"10.1016\/j.acap.2024.04.005_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12889-021-12425-w","article-title":"Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication","volume":"22","author":"Bass","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.acap.2024.04.005_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25539","article-title":"Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies","volume":"23","author":"Wilson","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.acap.2024.04.005_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/hiv.13451","article-title":"Long-acting injectable cabotegravir for PrEP: a game-changer in HIV prevention?","volume":"24","author":"Liegeon","year":"2023","journal-title":"HIV Med"},{"key":"10.1016\/j.acap.2024.04.005_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106220","article-title":"Long-acting drugs and formulations for the treatment and prevention of HIV infection","volume":"57","author":"Flexner","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.acap.2024.04.005_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25170","article-title":"Perspectives of South African youth in the development of an implant for HIV prevention","volume":"21","author":"Krogstad","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.acap.2024.04.005_bib21","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1007\/s10461-022-03708-3","article-title":"Gay, bisexual, and other men who have sex with men who are not on oral PrEP may be less interested in available injectable products than in oral PrEP: examining individual-level determinants of interest and barriers across products","volume":"26","author":"Wray","year":"2022","journal-title":"AIDS Behav"},{"key":"10.1016\/j.acap.2024.04.005_bib22","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s10461-017-1907-2","article-title":"Will gay and bisexual men taking oral pre-exposure prophylaxis (PrEP) switch to long-acting injectable PrEP should it become available?","volume":"22","author":"John","year":"2018","journal-title":"AIDS Behav"},{"key":"10.1016\/j.acap.2024.04.005_bib23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s10461-017-1972-6","article-title":"MSM at highest risk for HIV acquisition express greatest interest and preference for injectable antiretroviral PrEP compared to daily, oral medication","volume":"22","author":"Biello","year":"2018","journal-title":"AIDS Behav"},{"key":"10.1016\/j.acap.2024.04.005_bib24","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1186\/s12889-021-12015-w","article-title":"A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol","volume":"21","author":"Wood","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.acap.2024.04.005_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1521\/aeap.2021.33.4.312","article-title":"Usability evaluation of the mLab App for improving home HIV testing behaviors in youth at risk of HIV infection","volume":"33","author":"Sanabria","year":"2021","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.acap.2024.04.005_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jadohealth.2014.02.008","article-title":"Measuring youth health engagement: development of the youth engagement with health services survey","volume":"55","author":"Sebastian","year":"2014","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.acap.2024.04.005_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1179\/1753807615Y.0000000016","article-title":"Development of the health literacy assessment scale for adolescents (HAS-A)","volume":"8","author":"Manganello","year":"2015","journal-title":"J Commun Healthc"},{"key":"10.1016\/j.acap.2024.04.005_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12889-020-8154-6","article-title":"A randomized controlled efficacy trial of an electronic screening and brief intervention for alcohol misuse in adolescents and young adults vulnerable to HIV infection: step up, test up study protocol","volume":"20","author":"Kuhns","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.acap.2024.04.005_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108058","article-title":"Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs","volume":"117","author":"Shrestha","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.acap.2024.04.005_bib30","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s10461-016-1565-9","article-title":"Preferences for long-acting pre-exposure prophylaxis (PrEP), daily oral PrEP, or condoms for HIV prevention among US\u00a0men who have sex with men","volume":"21","author":"Greene","year":"2017","journal-title":"AIDS Behav"},{"key":"10.1016\/j.acap.2024.04.005_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209484","article-title":"Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with men","volume":"13","author":"Patel","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.acap.2024.04.005_bib32","first-page":"241","article-title":"Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence \u2013 a narrative review","volume":"7","author":"Haire","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"10.1016\/j.acap.2024.04.005_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/lgbt.2014.0114","article-title":"Ethical implications of social stigma associated with the promotion and use of pre-exposure prophylaxis for HIV prevention","volume":"3","author":"Herron","year":"2016","journal-title":"LGBT Health"},{"key":"10.1016\/j.acap.2024.04.005_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-024-04314-1","article-title":"Willingness to use long-acting injectable PrEP among PrEP Na\u00efve Black and Hispanic sexual gender minority persons","author":"Okafor","year":"2024","journal-title":"AIDS Behav"},{"key":"10.1016\/j.acap.2024.04.005_bib35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10461-021-03417-3","article-title":"Improved PrEP awareness and use among trans women in San Francisco, California","volume":"26","author":"Wilson","year":"2022","journal-title":"AIDS Behav"},{"key":"10.1016\/j.acap.2024.04.005_bib36","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1089\/apc.2019.0093","article-title":"Next-generation HIV pre-exposure prophylaxis preferences among men who have sex with men taking daily oral pre-exposure prophylaxis","volume":"33","author":"Ellison","year":"2019","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.acap.2024.04.005_bib37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10900-023-01195-8","article-title":"High interest in long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention among men who have sex with men (MSM): result from a nationwide survey in Malaysia","volume":"48","author":"Paudel","year":"2023","journal-title":"J Community Health"},{"key":"10.1016\/j.acap.2024.04.005_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/QAI.0000000000003370","article-title":"Barriers and facilitators to long-acting injectable HIV pre-exposure prophylaxis implementation in primary care since its approval in the United States","volume":"95","author":"Keddem","year":"2024","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Academic Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876285924001487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876285924001487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:46:44Z","timestamp":1724474804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876285924001487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1876285924001487"],"URL":"https:\/\/doi.org\/10.1016\/j.acap.2024.04.005","relation":{},"ISSN":["1876-2859"],"issn-type":[{"value":"1876-2859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis\u00a0Among Young Adult Sexual Minority Men and Transgender Women","name":"articletitle","label":"Article Title"},{"value":"Academic Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acap.2024.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 by Academic Pediatric Association All rights reserved.","name":"copyright","label":"Copyright"}]}}